OOIR: Observatory of International Research

Papers

(The TQCC of Critical Reviews in Microbiology is 17. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)

Article	Citations
Candida albicans biofilms and polymicrobial interactions	95
Antimicrobial resistance: more than 70 years of war between humans and bacteria	88
A review of antibiotic resistance in Group B Streptococcus: the story so far	65
Citric acid fromAspergillus niger: a comprehensive overview	64
Bacterial survival strategies and responses under heavy metal stress: a comprehensive overview	63
Severe fever with thrombocytopenia syndrome virus: a highly lethal bunyavirus	63
Inhibition ofStreptococcus mutansbiofilm formation by strategies targeting the metabolism of exopolysaccharides	54
Recent advances in tackling microbial multidrug resistance with essential oils: combinatorial and nano-based strategies	53
Inflammatory bowel disease: tri-directional relationship between microbiota, immune system and intestinal epithelium	52
Biological control as an alternative to synthetic fungicides for the management of grey and blue mould diseases of table grapes: a review	44
Global impact ofmcr-1-positiveEnterobacteriaceaebacteria on “one health”	42
Lung-brain axis	42
Advanced engineering of third-generation lysins and formulation strategies for clinical applications	41
Lipopeptide families at the interface between pathogenic and beneficialPseudomonas-plant interactions	39
Next-generation probiotics: a promising approach towards designing personalized medicine	39
Community-wide changes reflecting bacterial interspecific interactions in multispecies biofilms	39
Water in bacterial biofilms: pores and channels, storage and transport functions	38
Ways to control harmful biofilms: prevention, inhibition, and eradication	38
Exploiting solid lipid nanoparticles and nanostructured lipid carriers for drug delivery against cutaneous fungal infections	35
Helicobacter pylori infection: from standard to alternative treatment strategies	32
Treatment strategies targeting persister cell formation in bacterial pathogens	30
Akkermansia muciniphila plays critical roles in host health	29
Multi-omics tools for studying microbial biofilms: current perspectives and future directions	28
Candida albicanstargets that potentially synergize with fluconazole	27
Sneathia: an emerging pathogen in female reproductive disease and adverse perinatal outcomes	27

Microbial symbionts of insects as a source of new antimicrobials: a review	26
The role of the triggering receptor expressed on myeloid cells-1 (TREM-1) in non-bacterial infections	26
Extracellular polysaccharide biosynthesis in Cordyceps	26
Bdellovibrio bacteriovorus: a potential ‘living antibiotic’ to control bacterial pathogens	25
Mixed biofilms of pathogenic Candida-bacteria: regulation mechanisms and treatment strategies	25
The role of the probiotic Akkermansia muciniphila in brain functions: insights underpinning therapeutic potential	25
Polymicrobial interaction between Lactobacillus and Saccharomyces cerevisiae: coexistence-relevant mechanisms	24
Listeria monocytogenes: review of pathogenesis and virulence determinants-targeted immunological assays	24
Is there evidence for bacterial transfer via the placenta and any role in the colonization of the infant gut? – a systematic review	23
Bacterial infection and non-Hodgkin’s lymphoma	22
Highlighting the use of micro and nanoparticles based-drug delivery systems for the treatment of Helicobacter pylori infections	22
Nanosystems against candidiasis: a review of studies performed over the last two decades	22
Ambient air pollution and respiratory bacterial infections, a troubling association: epidemiology, underlying mechanisms, and future challenges	21
Diverse endophytic Streptomyces species with dynamic metabolites and their meritorious applications: a critical review	21
Resistance to peptidoglycan-degrading enzymes	21
Colonization ofHelicobacter pyloriin the oral cavity – an endless controversy?	21
Bacterial adhesion to collagens: implications for biofilm formation and disease progression in the oral cavity	20
Non-Melanoma Skin Cancer: news from microbiota research	20
Making a case for using γδ T cells against SARS-CoV-2	20
Rotavirus-related systemic diseases: clinical manifestation, evidence and pathogenesis	19
Applications of bacteriophages against intracellular bacteria	19
Role of the oral microbiome, metabolic pathways, and novel diagnostic tools in intra-oral halitosis: a comprehensive update	19
The role of microbial infection in the pathogenesis of Alzheimer’s disease and the opportunity for protection by anti-microbial peptides	18
Non-typeable Haemophilus influenzae chronic colonization in chronic obstructive pulmonary disease (COPD)	18
Guardian genes ensuring subsistence of oral Streptococcus mutans	18
Nisin resistance in Gram-positive bacteria and approaches to circumvent resistance for successful therapeutic use	18
Relevance of organ(s)-on-a-chip systems to the investigation of food-gut microbiota-host interactions	17
The era of Cas12 and Cas13 CRISPR-based disease diagnosis	17
Antimicrobial coatings for environmental surfaces in hospitals: a potential new pillar for prevention strategies in hygiene	17
Mycobacterium tuberculosis extracellular vesicles: exploitation for vaccine technology and diagnostic methods	17
EnterohepaticHelicobacterspecies – clinical importance, host range, and zoonotic potential	17